PTC Therapeutics | Passività Correnti



Current Liabilities Cambiamento Data
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amgen USD 23.01B 91M 2025-03
Biogen USD 5.3B 231.4M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Cytokinetics USD 159.73M 19.95M 2025-03
Daiichi Sankyo JPY 754.03B 41.68B 2025-03
Gilead Sciences USD 12B 279M 2024-12
Incyte USD 1.28B 608.18M 2025-06
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Ironwood Pharmaceuticals USD 39.15M 10.24M 2024-12
Novartis USD 31.71B 95M 2025-06
Pfizer USD 36.45B 6.54B 2025-03
PTC Therapeutics USD 595.39M 14.41M 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
TG Therapeutics USD 90.68M 34.43M 2024-12
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Xencor USD 88.44M 1M 2025-03


PTC Therapeutics Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.